The purpose of the study is to determine whether low-dose aspirin and low molecular weight heparin improve the implantation and pregnancy rates in patients with repeated implantation failures in IVF cycle.
The investigators hypothesize that cotreatment of low dose aspirin \& low molecular weight heparin may improve implantation \& clinical pregnancy rates.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
400
2500 mIU/day, subcutaneously
75 mg/day, orally
Aspirin (70 mg/day, orally) \& heparin (40 mg/day, subcutaneously)
Arpit Test Tube Baby Centre, Jeevan Jyoti Hospital & Research Centre
Allahābād, Uttar Pradesh, India
RECRUITINGBiological pregnancy test
Time frame: 14 days
Fetal heart/Gestational sac
Time frame: 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Equivalent volume of NaCl 0.9%, subcutaneously